1-benzylimidazole has been researched along with Gastric Ulcer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergamaschi, M; Caliari, S; Fossati, A; Gervasi, GB; Rapalli, L | 1 |
| Kauffman, GL; Moncada, S; Whittle, BJ | 1 |
2 other study(ies) available for 1-benzylimidazole and Gastric Ulcer
| Article | Year |
|---|---|
Prevention of experimentally induced gastric damage with the tripeptide ZAMI-420, a new thromboxane synthesis inhibitor.
Topics: Animals; Arachidonic Acids; Biological Assay; Carbenoxolone; Chromatography, Thin Layer; Cimetidine; Ethanol; Female; Guinea Pigs; Imidazoles; Oligopeptides; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Rabbits; Radioimmunoassay; Rats; Rats, Inbred Strains; Serotonin; Stomach; Stomach Ulcer; Thromboxane A2; Thromboxanes; Vasoconstriction | 1983 |
Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa.
Topics: Animals; Dogs; Imidazoles; Platelet Aggregation; Regional Blood Flow; Stomach; Stomach Ulcer; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Vasoconstriction | 1981 |